Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Nature

Volumn 447, Issue 7145, 2007, Pages 661-678

  Burton, Paul R ^a   Clayton, David G ^b   Cardon, Lon R ^c   Craddock, Nick ^d   Deloukas, Panos ^e   Duncanson, Audrey ^e   Kwiatkowski, Dominic P ^c,e   McCarthy, Mark I ^c,f   Ouwehand, Willem H ^g,h   Samani, Nilesh J ⁱ   Todd, John A ^b   Donnelly, Peter ^j   Barrett, Jeffrey C ^c   Davison, Dan ^j   Easton, Doug ^k   Evans, David ^c   Leung, Hin Tak ^b   Marchini, Jonathan L ^j   Morris, Andrew P ^c   Spencer, Chris C A ^j   Tobin, Martin D ^a   Attwood, Antony P ^e,g   Boorman, James P ^g,h   Cant, Barbara ^g   Everson, Ursula ^h   Hussey, Judith M ^h   Jolley, Jennifer D ^g   Knight, Alexandra S ^g   Koch, Kerstin ^g   Meech, Elizabeth ^l   Nutland, Sarah ^b   Prowse, Christopher V ^m   Stevens, Helen E ^b   Taylor, Niall C ^g   Walters, Graham R ^h   Walker, Neil M ^b   Watkins, Nicholas A ^g,h   Winzer, Thilo ^g   Jones, Richard W ⁿ   McArdle, Wendy L ⁿ   Ring, Susan M ⁿ   Strachan, David P ^o   Pembrey, Marcus ^n,p   Breen, Gerome ^q   St Clair, David ^q   Caesar, Sian ^r   Gordon Smith, Katherine ^d,r   Jones, Lisa ^r   Fraser, Christine ^d   Green, Elaine K ^d   Grozeva, Detelina ^d   Hamshere, Marian L ^d   Holmans, Peter A ^d   Jones, Ian R ^d   Kirov, George ^d   Moskvina, Valentina ^d   Nikolov, Ivan ^d   O'Donovan, Michael C ^d   Owen, Michael J ^d   Collier, David A ^s   Elkin, Amanda ^s   Farmer, Anne ^s   Williamson, Richard ^s   McGuffin, Peter ^s   Young, Allan H ^t   Ferrier, I Nicol ^t   Ball, Stephen G ^u   Balmforth, Anthony J ^u   Barrett, Jennifer H ^u   Bishop, D Timothy ^u   Iles, Mark M ^u   Maqbool, Azhar ^u   Yuldasheva, Nadira ^u   Hall, Alistair S ^u   Braund, Peter S ⁱ   Dixon, Richard J ⁱ   Mangino, Massimo ⁱ   Stevens, Suzanne ⁱ   Thompson, John R ^a   Bredin, Francesca ^g   Tremelling, Mark ^g   Parkes, Miles ^g   Drummond, Hazel ^v   Lees, Charles W ^v   Nimmo, Elaine R ^v   Satsangi, Jack ^v   Fisher, Sheila A ^w   Forbes, Alastair ^x   Lewis, Cathryn M ^w   Onnie, Clive M ^w   Prescott, Natalie J ^w   Sanderson, Jeremy ^y   Mathew, Christopher G ^w   Barbour, Jamie ^z   Mohiuddin, M Khalid ^z   Todhunter, Catherine E ^z   Mansfield, John C ^z   Ahmad, Tariq ^j   Cummings, Fraser R ^j   Jewell, Derek P ^j   Webster, John ^aa   Brown, Morris J ^g   Lathrop, G Mark ^ab   Connell, John ^ac   Dominiczak, Anna ^ac   Braga Marcano, Carolina A ^ad   Burke, Beverley ^ad   Dobson, Richard ^ad   Gungadoo, Johannie ^ad   Lee, Kate L ^ad   Munroe, Patricia B ^ad   Newhouse, Stephen J ^ad   Onipinla, Abiodun ^ad   Wallace, Chris ^ad   Xue, Mingzhan ^ad   Caulfield, Mark ^ad   Farrall, Martin ^c   Barton, Anne ^ae   Bruce, Ian N ^ae   Donovan, Hannah ^ae   Eyre, Steve ^ae   Gilbert, Paul D ^ae   Hider, Samantha L ^ae   Hinks, Anne M ^ae   John, Sally L ^ae   Potter, Catherine ^ae   Silman, Alan J ^ae   Symmons, Deborah P M ^ae   Thomson, Wendy ^ae   Worthington, Jane ^ae   Dunger, David B ^b,af   Widmer, Barry ^b,af   Frayling, Timothy M ^ag   Freathy, Rachel M ^ag   Lango, Hana ^ag   Perry, John R B ^ag   Shields, Beverley M ^ag   Weedon, Michael N ^ag   Hattersley, Andrew T ^ag   Hitman, Graham A ^ah   Walker, Mark ^t   Elliott, Kate S ^c,f   Groves, Christopher J ^f   Lindgren, Cecilia M ^c,f   Rayner, Nigel W ^c,f   Timpson, Nicholas J ^c,n   Zeggini, Eleftheria ^c,f   Newport, Melanie ^ai   Sirugo, Giorgio ^ai   Lyons, Emily ^c   Vannberg, Fredrik ^c   Hill, Adrian V S ^c   Bradbury, Linda A ^aj   Farrar, Claire ^f   Pointon, Jennifer J ^aj   Wordsworth, Paul ^f   Brown, Matthew A ^f,aj   Franklyn, Jayne A ^r   Heward, Joanne M ^r   Simmonds, Matthew J ^r   Gough, Stephen C L ^r   Seal, Sheila ^ak   Stratton, Michael R ^e,ak   Rahman, Nazneen ^ak   Ban, Sclerosis Maria ^al,am   Goris, An ^al,am   Sawcer, Stephen J ^al,am   Compston, Alastair ^al,am   Conway, David ^ai   Jallow, Muminatou ^ai   Rockett, Kirk A ^c   Bumpstead, Suzannah J ^e   Chaney, Amy ^e   Downes, Kate ^b,e   Ghori, Mohammed J R ^e   Gwilliam, Rhian ^e   Hunt, Sarah E ^e   Inouye, Michael ^e   Keniry, Andrew ^e   King, Emma ^e   McGinnis, Ralph ^e   Potter, Simon ^e   Ravindrarajah, Rathi ^e   Whittaker, Pamela ^e   Widden, Claire ^e   Withers, David ^e   Cardin, Niall J ^j   Ferreira, Teresa ^j   Pereira Gale, Joanne ^j   Hallgrimsdóttir, Ingileif B ^j   Howie, Bryan N ^j   Su, Zhan ^j   Teo, Yik Ying ^c,j   Vukcevic, Damjan ^j   Bentley, David ^e   Compston, Alistair ^al,am   more..

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h NHS BLOOD AND TRANSPLANT   (United Kingdom)

ⁱ UNIVERSITY OF LEICESTER   (United Kingdom)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^l Welsh Blood Service   (United Kingdom)

^m SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

ⁿ UNIVERSITY OF BRISTOL   (United Kingdom)

^o ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q UNIVERSITY OF ABERDEEN   (United Kingdom)

^r UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^s KING'S COLLEGE LONDON   (United Kingdom)

^t NEWCASTLE UNIVERSITY   (United Kingdom)

^u UNIVERSITY OF LEEDS   (United Kingdom)

^v WESTERN GENERAL HOSPITAL   (United Kingdom)

^w GUY S HOSPITAL   (United Kingdom)

^x UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^y GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^z NEWCASTLE UNIVERSITY   (United Kingdom)

^aa ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^ab CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^ac UNIVERSITY OF GLASGOW   (United Kingdom)

^ad QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^ae UNIVERSITY OF MANCHESTER   (United Kingdom)

^af UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ag PENINSULA MEDICAL SCHOOL   (United Kingdom)

^ah ROYAL LONDON HOSPITAL   (United Kingdom)

^ai MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^aj UNIVERSITY OF QUEENSLAND   (Australia)

^ak INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^al UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^am Illumina Cambridge   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; GENE EXPRESSION; GENOME; GENOTYPE; PATHOLOGY; PHENOTYPE;

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROHN DISEASE; GENE LOCUS; GENOME; GENOTYPE; HUMAN; HUMAN GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 84969213492     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05911     Document Type: Article

References (143)

1. Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nature Rev. Genet. 6, 95-108 (2005).
2. Barrett, J. C. & Cardon, L. R. Evaluating coverage of genome-wide association studies. Nature Genet. 38, 659-662 (2006).
3. The International HapMap consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
4. Murray, C. J. & Lopez, A. D. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 274, 740-743 (1996).
5. Mantel, N. Chi-square tests with one degree of freedom: Extension of the Mantel-Haenszel procedure. J. Am. Stat. Ass. 58, 690-700 (1963).
6. Colhoun, H. M., McKeigue, P. M. & Davey Smith, G. Problems of reporting genetic associations with complex outcomes. Lancet 361, 865-872 (2003).
7. Bersaglieri, T. et al. Genetic signatures of strong recent positive selection at the lactase gene. Am. J. Hum. Genet. 74, 1111-1120 (2004).
8. Coelho, M. et al. Microsatellite variation and evolution of human lactase persistence. Hum. Genet. 117, 329-339 (2005).
9. Sabeti, P. C. et al. Positive natural selection in the human lineage. Science 312, 1614-1620 (2006).
10. Todd, J. A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genet. advance online publication, doi:10.1038/ng2068 (6 June 2007).
11. Falush, D., Stephens, M. & Pritchard, J. K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567-1587 (2003).
12. Pritchard, J. K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945-959 (2000).
13. Menozzi, P., Piazza, A. & Cavalli-Sforza, L. Synthetic maps of human gene frequencies in Europeans. Science 201, 786-792 (1978).
14. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genet. 38, 904-909 (2006).
15. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997-1004 (1999).
16. Clayton, D. in Handbook of Statistical Genetics (eds Balding, D. J., Bishop, M. & Cannings, C.) 939-960 (Wiley, New York, 2003).
17. Mackay, T. F. & Anholt, R. R. Of flies and man: Drosophila as a model for human complex traits. Annu. Rev. Genomics Hum. Genet. 7, 339-367 (2006).
18. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. & Rothman, N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96, 434-442 (2004).
19. Zeggini, E. et al. Replication of genome-wide association signals in U.K. samples reveals risk loci for type 2 diabetes. Science online publication, doi:10.1126/science.1142364 (26 April 2007).
20. Steinthorsdottir, V. et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature Genet. advance online publication, doi:10.1038/ng2043 (26 April 2007).
21. Scott, L. J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science online publication, doi:10.1126/science.1142382 (26 April 2007).
22. Diabetes Genetics Institute. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science online publication, doi:10.1126/science.1142358 (26 April 2007).
23. Parkes, M. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nature Genet. advance online publication, doi:10.1038/ng2061 (6 June 2007).
24. Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
25. Cohen, J. C. et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305, 869-872 (2004).
26. Muller-Oerlinghausen, B., Berghofer, A. & Bauer, M. Bipolar disorder. Lancet 359, 241-247 (2002).
27. Craddock, N., O'Donovan, M. C. & Owen, M. J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 42, 193-204 (2005).
28. McGuffin, P. et al. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 60, 497-502 (2003).
29. Rice, J. et al. The familial transmission of bipolar illness. Arch. Gen. Psychiatry 44, 441-447 (1987).
30. McQueen, M. B. et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am. J. Hum. Genet. 77, 582-595 (2005).
31. Craddock, N. & Owen, M. J. The beginning of the end for the Kraepelinian dichotomy. Br. J. Psychiatry 186, 364-366 (2005).
32. Ozeki, Y. et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl Acad. Sci. USA 100, 289-294 (2003).
33. Blackwood, D. H. et al. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 69, 428-433 (2001).
34. Graves, T. D. & Hanna, M. G. Neurological channelopathies. Postgrad. Med. J. 81, 20-32 (2005).
35. Krystal, J. H. et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 7 (Suppl. 1), S71-S80 (2002).
36. Vawter, M. P. et al. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol. Psychiatry 7, 571-578 (2002).
37. Libby, P. & Theroux, P. Pathophysiology of coronary artery disease. Circulation 111, 3481-3488 (2005).
38. Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952 (2004).
39. Lusis, A. J., Mar, R. & Pajukanta, P. Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet. 5, 189-218 (2004).
40. Watkins, H. & Farrall, M. Genetic susceptibility to coronary artery disease: from promise to progress. Nature Rev. Genet. 7, 163-173 (2006).
41. Helgadottir, A. et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genet. 36, 233-239 (2004).
42. Helgadottir, A. et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nature Genet. 38, 68-74 (2006).
43. Topol, E. J., Smith, J., Plow, E. F. &Wang, Q. K. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum. Mol. Genet. 15 (Spec. No. 2), R117-R123 (2006).
44. Lowe, S. W. & Sherr, C. J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77-83 (2003).
45. INK4Bis a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261 (1994).
46. Kalinina, N. et al. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-β/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler. Thromb. Vasc. Biol. 24, 1391-1396 (2004).
47. Schmid, M. et al. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene 19, 5747-5754 (2000).
48. 1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls. J. Biol. Chem. 278, 43178-43187 (2003).
49. 1-tetrahydrofolate synthase. Arch. Biochem. Biophys. 442, 196-205 (2005).
50. Frosst, P. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 10, 111-113 (1995).
51. Klerk, M. et al. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. J. Am. Med. Assoc. 288, 2023-2031 (2002).
52. 3]serine allows in vivo kinetic measurement of serine turnover, homocysteine remethylation, and transsulfuration processes in human one-carbon metabolism. Am. J. Clin. Nutr. 72, 1535-1541 (2000).
53. Randak, C. et al. Three siblings with nonketotic hyperglycinaemia, mildly elevated plasma homocysteine concentrations and moderate methylmalonic aciduria. J. Inherit. Metab. Dis. 23, 520-522 (2000).
54. Wight, T. N. The ADAMTS proteases, extracellular matrix, and vascular disease - Waking the sleeping giant(s)! Arterioscler. Thromb. Vasc. Biol. 25, 12-14 (2005).
55. Jonsson-Rylander, A. et al. The role of ADAMTS-1 in atherosclerosis: Remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arter. Thromb. Vas. Bio. 25, 180-185 (2004).
56. Travis, S. P. et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 55 (Suppl. 1), i16-i35 (2006).
57. Sartor, R. B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nature Clin. Pract. Gastroenterol. Hepatol. 3, 390-407 (2006).
58. Tysk, C., Lindberg, E., Jarnerot, G. & Floderusmyrhed, B. Ulcerative-colitis and Crohns-disease in an unselected population of monozygotic and dizygotic twins - a study of heritability and the influence of smoking. Gut 29, 990-996 (1988).
59. Gaya, D. R., Russell, R. K., Nimmo, E. R. & Satsangi, J. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 367, 1271-1284 (2006).
60. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
61. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
62. Rioux, J. D. et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genet. 29, 223-228 (2001).
63. Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
64. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nature Genet. 39, 207-211 (2007).
65. Rioux, J. D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nature Genet. 39, 596-604 (2007).
66. Libioulle, C. et al. Novel crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).
67. Singh, S. B., Davis, A. S., Taylor, G. A. & Deretic, V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438-1441 (2006).
68. Leonard, E. J. Biological aspects of macrophage-stimulating protein (MSP) and its receptor. Ciba Found Symp. 212, 183-191; discussion 192-197 (1997).
69. Pabst, O., Forster, R., Lipp, M., Engel, H. & Arnold, H. H. NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue. EMBO J. 19, 2015-2023 (2000).
70. Yamazaki, K. et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 14, 3499-3506 (2005).
71. Pietravalle, F. et al. Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J. Biol. Chem. 271, 5965-5967 (1996).
72. Battegay, E. J., Lip, G. Y. H. &Badris, G. L. (eds) Hypertension; Principles and Practice (Taylor Francis Group, 2005).
73. Kobberling, J. & Tattersall, R. (eds) The Genetics of Diabetes Mellitus (Academic Press, London, 1982).
74. Dominiczak, A. F. et al. Genetics of hypertension: Lessons learnt from Mendelian and polygenic syndromes. Clin. Exp. Hypertens. 26, 611-620 (2004).
75. Mein, C. A., Caulfield, M. J., Dobson, R. J. & Munroe, P. B. Genetics of essential hypertension. Hum. Mol. Genet. 13, R169-R175 (2004).
76. Hubner, N. et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nature Genet. 37, 243-253 (2005).
77. Caulfield, M. et al. Genome-wide mapping of human loci for essential hypertension. Lancet 361, 2118-2123 (2003).
78. Newhouse, S. J. et al. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study. Hum. Mol. Genet. 14, 1805-1814 (2005).
79. Tobin, M. D. et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 112, 3423-3429 (2005).
80. 2+release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 13472-13483 (1990).
81. Benkusky, N. A., Farrell, E. F. & Valdivia, H. H. Ryanodine receptor channelopathies. Biochem. Biophys. Res. Commun. 322, 1280-1285 (2004).
82. Worthington, J., Barton, A. & John, S. L. The epidemiology of rheumatoid arthritis and the use of linkage and association studies to identify disease genes (Birkhauser, Basel, 2005).
83. Wordsworth, P. & Bell, J. Polygenic susceptibility in rheumatoid arthritis. Ann. Rheum. Dis. 50, 343-346 (1991).
84. Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205-1213 (1987).
85. Jawaheer, D. et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68, 927-936 (2001).
86. John, S. et al. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am. J. Hum. Genet. 75, 54-64 (2004).
87. MacKay, K. et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46, 632-639 (2002).
88. Begovich, A. B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330-337 (2004).
89. Hinks, A., Eyre, S., Barton, A., Thomson, W. & Worthington, J. Investigation of genetic variation across PTPN22 in UK rheumatoid arthritis (RA) patients. Ann. Rheum. Dis. 66, 683-686 (2006).
90. Sharfe, N., Dadi, H. K., Shahar, M. & Roifman, C. M. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc. Natl Acad. Sci. USA 94, 3168-3171 (1997).
91. Vella, A. et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76, 773-779 (2005).
92. Devendra, D., Liu, E. & Eisenbarth, G. S. Type 1 diabetes: recent developments. Br. Med. J. 328, 750-754 (2004).
93. Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M. & Tuomilehto, J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52, 1052-1055 (2003).
94. Smyth, D. J. et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nature Genet. 38, 617-619 (2006).
95. Todd, J. A. Statistical false positive or true disease pathway? Nature Genet. 38, 731-733 (2006).
96. Mustelin, T., Vang, T. & Bottini, N. Protein tyrosine phosphatases and the immune response. Nature Rev. Immunol. 5, 43-57 (2005).
97. Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genet. 36, 337-338 (2004).
98. Brand, O. J. Association of the interleukin-2 receptor alpha (IL-2Rα)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin. Endocrinol. 66, 508-512 (2007).
99. Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nature Genet. 39, 329-337 (2007).
100. Zimmet, P., Alberti, K. G. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782-787 (2001).
101. Stumvoll, M., Goldstein, B. J. & van Haeften, T. W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346 (2005).
102. Altshuler, D. et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genet. 26, 76-80 (2000).
103. Gloyn, A. L. et al. Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568-572 (2003).
104. Grant, S. F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genet. 38, 320-323 (2006).
105. Zeggini, E. & McCarthy, M. I. TCF7L2: the biggest story in diabetes genetics since HLA? Diabetologia 50, 1-4 (2007).
106. Helgason, A. et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genet. 39, 218-225 (2007).
107. Saxena, R. et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55, 2890-2895 (2006).
108. Ubeda, M., Rukstalis, J. M. & Habener, J. F. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic β cells from glucotoxicity. J. Biol. Chem. 281, 28858-28864 (2006).
109. Sladek, R. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885 (2007).
110. Marchini, J., Donnelly, P. & Cardon, L. R. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nature Genet. 37, 413-417 (2005).
111. Clayton, D. G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nature Genet. 37, 1243-1246 (2005).
112. Zondervan, K. T. & Cardon, L. R. The complex interplay among factors that influence allelic association. Nature Rev. Genet. 5, 89-100 (2004).
113. Hutchison, K. E., Stallings, M., McGeary, J. & Bryan, A. Population stratification in the candidate gene study: fatal threat or red herring? Psychol. Bull. 130, 66-79 (2004).
114. Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S. & Hirschhorn, J. N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genet. 33, 177-182 (2003).
115. Hayes, B. & Goddard, M. E. The distribution of the effects of genes affecting quantitative traits in livestock. Genet. Sel. Evol. 33, 209-229 (2001).
116. Valdar, W. et al. Genome-wide genetic association of complex traits in heterogeneous stock mice. Nature Genet. 38, 879-887 (2006).
117. Yang, Q., Khoury, M. J., Friedman, J., Little, J. & Flanders, W. D. How many genes underlie the occurrence of common complex diseases in the population? Int. J. Epidemiol. 34, 1129-1137 (2005).
118. Janssens, A. C. et al. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet. Med. 8, 395-400 (2006).
119. Spitzer, R. L., Endicott, J. & Robins, E. Research diagnostic criteria: rationale and reliability. Arch. Gen. Psychiatry 35, 773-782 (1978).
120. Wing, J. K. B. T. et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch. Gen. Psychiatry 47, 589-593 (1990).
121. Craddock, M. et al. Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br. J. Psychiatry 169, 58-63 (1996).
122. McGuffin, P., Farmer, A. & Harvey, I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 48, 764-770 (1991).
123. Green, E. K. et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch. Gen. Psychiatry 62, 642-648 (2005).
124. Green, E. K. et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br. J. Psychiatry 188, 21-25 (2006).
125. Samani, N. J. et al. A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am. J. Hum. Genet. 77, 1011-1020 (2005).
126. Lennard-Jones, J. E. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. (Suppl.) 170, 2-6; discussion 6-9 (1989).
127. Arnett, F. C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324 (1988).
128. MacGregor, A. J., Bamber, S. & Silman, A. J. A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J. Rheumatol. 21, 1420-1426 (1994).
129. Worthington, J. et al. The Arthritis and Rheumatism Council's National Repository of Family Material: pedigrees from the first 100 rheumatoid arthritis families containing affected sibling pairs. Br. J. Rheumatol. 33, 970-976 (1994).
130. Symmons, D. P., Barrett, E. M., Bankhead, C. R., Scott, D. G. & Silman, A. J. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br. J. Rheumatol. 33, 735-739 (1994).
131. Smyth, D. et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53, 3020-3023 (2004).
132. Wiltshire, S. et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69, 553-569 (2001).
133. Frayling, T. M. et al. Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes 48, 2475-2479 (1999).
134. Groves, C. J. et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55, 2640-2644 (2006).
135. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41 (2006).
136. Strachan, D. P. et al. Lifecourse influences on health among British adults: Effects of region of residence in childhood and adulthood. Int. J. Epidemiol. Advance online publication, doi:10.1093/ije/dyl309 (25 January 2007).
137. Matsuzaki, H. et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. 1, 104-105. Nat Methods 1, 104-105 (2004).
138. Di, X. et al. Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics 21, 1958-1963 (2005).
139. Rabbee, N. & Speed, T. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 22, 7-12 (2006).
140. Affymetrix. in Technical Report (2006).
141. Stirling, W. D. Enhancements to Aid Interpretation of Probability Plots. Statistician 31, 211-220 (1982).
142. Li, N. & Stephens, M. Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data. Genetics 165, 2213-2233 (2003).
143. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies via imputation of genotypes. Nature Genet. doi:10.1038/ng2088 (in the press).